Fractyl Health, Inc. Common StockGUTSNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
85.26%
↑ 238% above average
Average (5y)
25.20%
Historical baseline
Range
High:85.26%
Low:0.00%
Volatility
338.4%
High variability
| Period | Value |
|---|---|
| 2024 | 85.26% |
| 2023 | 10.72% |
| 2022 | 29.96% |
| 2021 | 17.84% |
| 2020 | 7.41% |
| 2019 | 0.00% |